Biotech Values

[DewDiligence]

IDIX Insider Shareholdings

[Updated for hiring of General Counsel, Maria Stahl (#msg-55504379).
Options listed below include vested and non-vested holdings.]

 
                             Shares     Options 

Officers
JP Sommadossi (CEO)† 2,219,754 1,806,250
Ron Renaud (CFO) 15,000 555,000
Doug Mayers (CMO) 30,000 300,000
David Standring (EVP/Bio) 67,575 150,000
Maria Stahl (Gen Counsel)‡ 0 150,000
Paul Fanning (SVP/HR) 1,333 235,000

Directors
Charles Cramb 7,200 160,000
Wayne Hockmeyer 41,708 120,000
Thomas Hodgson 92,324 120,000
Tamar Howson 0 38,333
Denise Pollard-Knight 0 100,000
Robert Pelzer* 0 0
Anthony Rosenberg* 0 0
======================== ========= =========
All 13 insiders 2,474,894 4,034,583
*Directors appointed by NVS; they do not directly own IDIX
shares or options, but NVS itself is a major shareholder.

†Sommadossi is also Chairman of the BoD.

‡Hired 10/13/10.